CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Kokua Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kolmask Ld — — —
60
40% 		7/20/2026 View Intelligence
Korea Otsuka Pharmaceutical 8 trials — —
60
36% 		7/17/2026 View Intelligence
Korean Pharmacoacupuncture Institute — — —
60
36% 		7/17/2026 View Intelligence
Koronis Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kos Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kotra Pharma (m) Sdn Bhd — — —
60
36% 		7/17/2026 View Intelligence
Kowa Pharmaceuticals America — — —
60
36% 		7/17/2026 View Intelligence
Kpc Pharmaceuticals 1 trials — —
60
36% 		7/17/2026 View Intelligence
Kramer Laboratories — — —
60
41% 		7/20/2026 View Intelligence
Kramer Novis — — —
60
42% 		7/20/2026 View Intelligence
Kringle Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kringle Pharma Europe — — —
60
36% 		7/17/2026 View Intelligence
Kriya Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kroger — — —
60
42% 		7/20/2026 View Intelligence
Ksq Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kth Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Kudos Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kuhnil Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Kukje Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kukjeon Pharmaceutical Coltd — — —
60
36% 		7/17/2026 View Intelligence
Kumquat Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Kun Tuo Xincheng Pharmaceutical Researchand Development(beijing)coltd — — —
60
36% 		7/17/2026 View Intelligence
Kungpo Health Care & Herbal Center — — —
60
40% 		7/20/2026 View Intelligence
Kunming Baker Norton Pharmaceutical Sales — — —
60
36% 		7/17/2026 View Intelligence
Kunming Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kunwha Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Kuros Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Kutol Products — — —
60
40% 		7/20/2026 View Intelligence
Kuzani Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kwang Dong Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Kylonova (xiamen) Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Kymera Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Kyongbo Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Kyongbo Pharmaceutical Coltd — — —
60
36% 		7/17/2026 View Intelligence
Kyorin Pharmaceutical Coltd 3 trials — —
60
36% 		7/17/2026 View Intelligence
Kyowa Hakko Kirin Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kyowa Kirin — — —
60
40% 		7/20/2026 View Intelligence
Kyowa Kirin China Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Kyowa Kirin Pharmaceutical Development 2 trials — —
60
36% 		7/17/2026 View Intelligence
Kythera Biopharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kyungdong Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Kyverna Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
L Perrigo — — —
60
42% 		7/20/2026 View Intelligence
L'Oreal USA Products — — —
60
42% 		7/20/2026 View Intelligence
LABORATOIRES DERMO-COSMETIK — — —
60
40% 		7/20/2026 View Intelligence
LABORATOIRES DRUIDE — — —
60
42% 		7/20/2026 View Intelligence
LABORATOIRES M&L — — —
60
40% 		7/20/2026 View Intelligence
LALANI Rx Consulting — — —
60
40% 		7/20/2026 View Intelligence
LAMOIYAN — — —
60
40% 		7/20/2026 View Intelligence
Showing 3301 - 3350 of 6,643 companies